Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,241 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $249.19 | 2 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $237.30 | 11 | $0 (2024) |
| Ardelyx, Inc. | $186.46 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $149.10 | 1 | $0 (2024) |
| Vifor Pharma, Inc. | $148.89 | 2 | $0 (2024) |
| Calliditas Therapeutics US Inc. | $100.18 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $95.47 | 1 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $49.14 | 2 | $0 (2024) |
| Amgen Inc. | $25.10 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $876.22 | 25 | Fresenius USA Marketing, Inc. ($237.30) |
| 2023 | $364.61 | 5 | Otsuka America Pharmaceutical, Inc. ($124.27) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $149.10 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/26/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $91.45 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/27/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $124.92 | General |
| Category: NEPHROLOGY | ||||||
| 04/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hyperkalemia | ||||||
| 03/28/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $23.89 | General |
| 03/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/02/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: NEPHROLOGY | ||||||
| 01/25/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: Phosphate binder for ESRD | ||||||
About Michael David, NP
Michael David, NP is a Nephrology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2022. The National Provider Identifier (NPI) number assigned to this provider is 1881318699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael David, NP has received a total of $1,241 in payments from pharmaceutical and medical device companies, with $876.22 received in 2024. These payments were reported across 30 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,241).
Practice Information
- Specialty Nephrology
- Other Specialties Family
- Location Virginia Beach, VA
- Active Since 09/27/2022
- Last Updated 03/22/2023
- Taxonomy Code 163WN0300X
- Entity Type Individual
- NPI Number 1881318699
Products in Payments
- JYNARQUE (Drug) $249.19
- Velphoro (Drug) $237.30
- Kerendia (Drug) $149.10
- Veltassa (Drug) $125.00
- IBSRELA (Drug) $111.46
- TARPEYO (Drug) $100.18
- XPHOZAH 30 MG (Drug) $75.00
- Auryxia (Drug) $49.14
- TAVNEOS (Drug) $25.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.